Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...